• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

FASEB J . Variation in ORF3a Protein of SARS-CoV-2 Decreases The Severity of Host Cell Damage

tetano

Editor, Senior Moderator
FASEB J


. 2022 May;36 Suppl 1.
doi: 10.1096/fasebj.2022.36.S1.R4149.
Variation in ORF3a Protein of SARS-CoV-2 Decreases The Severity of Host Cell Damage


Maria Landherr[SUP] 1 [/SUP], Michael W Cypress[SUP] 1 [/SUP], Isabel Chaput[SUP] 1 [/SUP], Bong Sook Jhun[SUP] 1 [/SUP], Jin O-Uchi[SUP] 1 [/SUP], Iuliia Polina[SUP] 1 [/SUP]



Affiliations

Abstract

Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily targets the respiratory system. However, direct SARS-CoV-2 infection and viral protein expression have also been reported in other organs, which potentially contributes to multi-organ dysfunction and increased mortality in COVID-19. Since the original Wuhan-type genome was sequenced, several genetic variants of SARS-CoV-2 have emerged with differing pathophysiological properties such as the levels of transmissibility, disease severity, and mortality. We previously reported that the protein encoded by open reading frame 3a (ORF3a), a critical protein for SARS-CoV-2 replication and release, is found in the mitochondria of host cells and could increase oxidative stress and apoptotic signaling. ORF3a-Q57H is a highly recurrent variation and the most commonly found variant of ORF3a. Interestingly, the Q57H variant is associated with increased transmissibility, but lower mortality.
Aim: To investigate the impact of the ORF3a-Q57H variant on host cell damage.
Methods: Plasmids carrying ORF3a-Q57H were generated by PCR-based site mutagenesis using Wuhan-type ORF3a (ORF3a-WT) as a template. Whole cell lysates were prepared from HEK293T cells and H9c2 cardiac myoblasts expressing ORF3a-WT or the mutant ORF3a-Q57H and used for biochemical assays. Live cell imaging for assessing subcellular localization of ORF3a/ORF3a-Q57H, mitochondrial reactive oxygen species (mROS), and caspase 3 activity in H9c2 cells was performed by confocal microscopy.
Results: In whole cell lysates, we found that ORF3a-Q57H exhibits significantly higher protein expression compared to ORF3a-WT. However, there is no significant difference in the ability of mitochondrial trafficking between ORF3a-WT and ORF3a-Q57H assessed by live cell imaging using GFP-tagged ORF3a/ORF3a-Q57H with mitochondria-targeted DsRed. Next, we investigated the effects of ORF3a expression on apoptotic and mitophagy signaling by quantifying the caspase 3 activity and LC3A/B ratio. We found that ORF3a-Q57H has significantly lower apoptosis and mitophagy signaling compared to WT despite its higher protein expression levels. ER-stress signaling was not activated in either ORF3a-WT or ORF3a-Q57H, as assessed by markers including Glucose-regulated protein 78/94 and C/EBP-homologous protein. Lastly, live cell imaging using the mitochondrial superoxide-sensitive dye Mitosox Red revealed that ORF3a-WT significantly increases mROS levels, but ORF3a-Q57H expression does not.
Conclusion: SARS-CoV-2-ORF3a-Q57H causes lower oxidative stress and cell damage compared to the Wuhan-type variant, which could help explain the decreased mortality associated with the ORF3a-Q57H variant. These results provide novel insights on how genetic variations of SARS-CoV-2 influence the pathophysiology and clinical severity of COVID-19.
 
Back
Top Bottom